406-896-5876 Feel free to call us!
info@montanabio.org Get in touch today!
1500 University Drive Apsaruke Hall #111, Billings, Montana 59101
toggle menu

Presentation by MWTC -Technology Commercialization, Tech Transfer and IP Protection

Learn from your peers with a live case study featuring Ron Zook, CEO & Founder of Swan Valley Medical talking about his experience with technology commercialization, product development, scaling and more. TechEx team member, Toni Tease, Daniel Juliano, Director of the Technology Transfer Office at MSU, and Ann Peterson , SBIR Outreach Program manager, will […]

University of Montana disease treatment research center pulls in $22 million in grants

A research center at the University of Montana earned $22.4 million this summer and fall from the National Institutes of Health. “It’s validated that what we set up in Missoula through this Center for Translational Medicine is working to advance discoveries at the University of Montana,” said Jay Evans, center director and research professor in […]

MSU’s biomarker-detecting technology licensed to FYR Diagnostics

A Montana State University technology anticipated to improve the accuracy of medical diagnoses has been licensed by FYR Diagnostics, a biotech company in Missoula. The license agreement transfers to FYR Diagnostics a molecule detection technology developed by Stephanie McCalla, assistant professor in MSU’s Chemical and Biological Engineering Department, and Tomas Gedeon, professor in the Department of Mathematical Sciences. […]

Apply for NCATS SBIR/STTR Funding by Sept. 5

Prepare Your 2018 Omnibus Solicitation Application for  Small Business Innovation Research and Technology Transfer Grants  Application deadline: Sept. 5, 2018, 5:00 p.m. local time The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites small businesses to apply for funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) 2018 […]

Broadening the Conversation About Drug Pricing

The New York Times editorial board recently observed: “We shouldn’t be surprised by any biotech’s failure. We should expect it. Biotechs by their nature offer the promise of disruptive breakthroughs and discoveries, but they’re mostly all-in propositions, based on one molecule or one test. Fail in a Phase III clinical trial — and a majority do — […]

Smithsonian magazine publishes story about impact of MSU alum, vaccinologist Maurice Hilleman

Smithsonian magazine publishes story about impact of MSU alum, vaccinologist Maurice Hilleman From MSU News Service FEBRUARY 23, 2018   BOZEMAN — The work and impact of a Montana State University alumnus was featured recently in a prominent national forum. “You Should Thank Maurice Hilleman for Helping You Live Past the Age of 10”was published […]

Exploring the Richness of Companies & Investors at the BIO Forum

The BIO Investor Forum is the premier event for emerging private and public companies to connect with prospective investors to make the deals that drive our industry. More than 220 investors are already registeredfor this year, with one month to go. The foundation for the success of an event of such magnitude as BIO Investor Forum rests on […]

Climbing The Funding Ladder in Research and Drug Development

Climbing The Funding Ladder in Research and Drug Development



Now Accepting Applications for Three ITHS Career Development Programs

Stan Abel

Montana BioScience Alliance Elects New Chairman and Board Members

Stan Abel of SiteOne Therapeutics to Serve as Chairman Of the Board of Montana’s Leading Biotechnology Innovation Organization; Jay Evans of Inimmune and Tim Layton of Genentech Elected to the Board of Directors   Billings, MT – Wednesday, August 16, 2017 – The Montana BioScience Alliance recently elected three new board members and appointed new […]